The smaller total CD8+ T cell population in RA-MTX patients was mainly driven by fewer CD8+ Tnaïve cells compared to HCs throughout the duration of the study (Figure 5c and Figure 5—figure supplement 1c). This evidence concerns the gene CD8A and rheumatoid arthritis.